Article Information
vol. 4 no. 1
Published By
Online ISSN
History
- Received June 16, 2017
- Accepted October 21, 2017
- Published online January 5, 2018.
Copyright & Usage
Copyright ©ERS 2018 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
Author Information
- John H. Riley1⇑,
- Chris J. Kalberg2,
- Alison Donald2,
- David A. Lipson3,4,
- Muhammad Shoaib5 and
- Lee Tombs6
- 1GlaxoSmithKline Respiratory Franchise, Brentford, UK
- 2Respiratory and Immuno-Inflammation, GlaxoSmithKline, Research Triangle Park, NC, USA
- 3Respiratory Clinical Development, GlaxoSmithKline, King of Prussia, PA, USA
- 4Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
- 5MDC Global Clinical Development UK, Respiratory R&D, GlaxoSmithKline, Uxbridge, UK
- 6Precise Approach Ltd, Uxbridge, UK
- John Riley, GlaxoSmithKline Respiratory Franchise, GSK House, 980 Great West Road, Brentford, TW8 9GS, UK. E-mail: john.h.riley{at}gsk.com
Funding
GSK
NCT02275052; GSK identifier: 201317